Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Mol Biol (Mosk) ; 54(5): 725-749, 2020.
Article in Russian | MEDLINE | ID: mdl-33009787

ABSTRACT

Depression is a serious mental disorder that affects more than 300 million people worldwide. Due to the lack of effective treatment methods, the pathogenesis of depression is necessary to study in order to understand its development and find new therapies. The review describes the main mechanisms of depression, including the monoamine hypothesis, impairment of the hipotalamic-pituitary-adrenal axis, decreased production of neurotropic factors, and neuroinflammation. Genetic correlations, gene polymorphisms, and epigenetic mechanisms are also considered. Common and different features of the etiology are analyzed for depression and depressive conditions associated with other pathologies (schizophrenia, Parkinson disease, and Alzheimer's disease). Modern experimental methods used to investigate the molecular mechanisms of depressive conditions are described with a focus on gene knockouts in laboratory animals and the CRISPR/Cas technology. Consideration is given to optogenetic and chemogenetic methods and analyses of genetic polymorphisms and their combinations. The data may provide for a better integral understanding of the modern ideas about the pathogenesis of depression as an isolated or comorbid disorder and the prospects in studying the mechanisms of depressive conditions.


Subject(s)
Depressive Disorder , Animals , CRISPR-Cas Systems , Depressive Disorder/genetics , Disease Models, Animal , Gene Knockdown Techniques , Humans , Polymorphism, Genetic
2.
Zh Nevrol Psikhiatr Im S S Korsakova ; 120(6. Vyp. 2): 31-36, 2020.
Article in Russian | MEDLINE | ID: mdl-32729688

ABSTRACT

OBJECTIVE: To determine the frequency of the key psychopathological syndromes, the dynamics and comorbidity of schizophrenia and other psychoses in Russian veterans of local wars receiving hospital treatment. MATERIAL AND METHODS: The study included 685 patients of a psychiatric department of a military hospital, including 264 veterans of the local wars (the main group), 296 people (career military servicemen and retirees), who do not take part in combat actions (the first comparison group) and 125 people matched for the middle age and the age distribution curve with the main group (the second comparison group). RESULTS AND CONCLUSION: The frequency of psychoses appeared to be slightly less in veterans (7.2%) compared to patients of comparison groups (14.5% and 8.8%, respectively). In all groups, most patients were diagnosed with schizophrenia (ICD-10 F20): 3.8% in the main group, 4.4% in the first comparison group and 4.0% in the second comparison group. Other acute and chronic psychotic disorders (F22-F23) were diagnosed in 0.8, 5.4 and 3.2% patients, respectively. Organic delusion disorders were diagnosed in 1.5% patients of the main group, 3.7% patients of the first comparison group and were not detected in the second comparison group. Comorbidity of posttraumatic stress disorder (PTSD) and psychosis was about 2% in the main group in whole and 26.3% in those with schizophrenia and other delusional disorders. The degree of incidence of symptoms of PTSD in veterans diagnosed with psychosis was significantly less than their frequency among all veterans (20% and 46.9%, respectively). Military stress factors do not influence the development of hallucinations and delusions in the main group. In the majority of veterans, psychotic symptoms manifested for the first time after stopping combat stress, the subsequent development and recurrence of psychotic symptoms happened regardless of the influence of combat stress factors.


Subject(s)
Psychotic Disorders/epidemiology , Schizophrenia , Stress Disorders, Post-Traumatic/epidemiology , Veterans , Comorbidity , Humans , Middle Aged , Russia
3.
Zh Nevrol Psikhiatr Im S S Korsakova ; 120(6. Vyp. 2): 54-60, 2020.
Article in Russian | MEDLINE | ID: mdl-32729691

ABSTRACT

OBJECTIVE: To determine the network connections between clinical, cognitive, speech and oculographic parameters in patients with schizophrenia. MATERIAL AND METHODS: The study included 104 patients with schizophrenia and schizophrenia spectrum disorders and 70 healthy subjects. Clinical assessment of the patients was performed using a number of scales: PANSS, CDSS, YMRS, SAS and BAS. Basic cognitive functions were assessed by BACS. Eye movements were recorded using the SMI RED-500 non-invasive eye tracking system. Several experimental paradigms were used - free viewing of animal images with subsequent description of these images, performing progressive saccades in the experimental Go/NoGo scheme, and performing anti-saccades. RESULTS: The severity of clinical symptoms, cognitive impairments, oculomotor parameters and characteristics of speech structure of written speech are largely independent, although not completely isolated from each other. Cognitive and oculomotor parameters have the largest number of connections. In this case, the results of cognitive tests are the central element of the «network¼ that connects other groups. CONCLUSION: Further development of the approach should be aimed at studying the influence of node changes on the structure of the network that would potentially allows the identification of the most effective points of application of therapeutic and rehabilitation programs.


Subject(s)
Eye Movements , Schizophrenia , Animals , Cognition , Humans , Saccades , Speech
4.
Zh Nevrol Psikhiatr Im S S Korsakova ; 120(6. Vyp. 2): 68-76, 2020.
Article in Russian | MEDLINE | ID: mdl-32729693

ABSTRACT

OBJECTIVE: An analysis of the efficacy and safety of additional therapy of excitement with the injectable form of alimemazine during exacerbations of schizophrenia with psychomotor agitation, impulsivity, including dangerous behavior, irritability, conflict, hostility, aggressiveness, anxiety, sleep disturbances (insomnia). MATERIAL AND METHODS: Thirty patients, aged 18 to 65 years, with a diagnosis of «paranoid schizophrenia¼, established in accordance with the ICD-10 criteria, were studied. The patients received treatment with a second-generation antipsychotic and alimemazine (intramuscular injection solution) in daily dose from 25 mg to 150 mg during no more than 9 days. The patients were assessed with psychometric scales (PANSS, ABS, HARS and VAS) four times during the observation period. RESULTS AND CONCLUSION: During therapy with a combination of second-generation antipsychotics and alimemazine solution for intramuscular injection, a reliable (p<0.001) reduction in the severity of psychotic symptoms assessed with PANSS was achieved by 8-9 days (the average total score decreased by 30% relative to the initial level) that indicated the improvement in all manifestations of schizophrenia exacerbation. A decrease of 34.8% (p=0.007) in the risk of aggression (PANSS points S1-S3) was established. The level of excitation on the agitation scale (ABS) decreased by 3.6% (p<0.001). In 50% of patients, manifestations of anxiety disappeared, and the average HARS score decreased by 2.2 times compared with the initial level (p<0.001). Almost half of the patients noted the normalization of sleep, and the average value of sleep disturbance on a visual analogue scale decreased threefold compared with the initial level (p<0.001). The observed adverse events were moderate or mild. Alimemazine shows the highest efficacy in the treatment of anxiety arousal in patients with schizophrenia with affective-delusional attacks.


Subject(s)
Antipsychotic Agents/therapeutic use , Schizophrenia/drug therapy , Adolescent , Adult , Aged , Anxiety , Humans , Middle Aged , Psychiatric Status Rating Scales , Psychomotor Agitation/drug therapy , Treatment Outcome , Trimeprazine/therapeutic use , Young Adult
5.
Article in Russian | MEDLINE | ID: mdl-31626230

ABSTRACT

The review is devoted to the analysis of the current state of pharmacogenetic research and their use in psychiatric practice. The main genes responsible for the pharmacodynamics and pharmacokinetics of drugs used in psychiatry are listed. Foreign pharmacogenetic clinical recommendations and progress on their implementation in medical practice in various countries of Europe and the USA are analyzed. The need to create Russian clinical guidelines on pharmacogenomics to improve the effectiveness of patient care and to implement a personalized approach to therapy is discussed.


Subject(s)
Neurology , Pharmacogenetics , Psychiatry , Europe , Humans , Russia , United States
6.
Article in Russian | MEDLINE | ID: mdl-28745683

ABSTRACT

Schizophrenia is a disease with a complex non-Mendelian inheritance mechanism in most cases involving the combined action of a large number of genes. Identifying of genomic variations associated with schizophrenia endophenotypes has a great potential. This review describes genetic markers of the disease, current methods of their analysis, including genome-wide association study (GWAS). Certain genes with mutations that increase the risk of schizophrenia are described. Functional polymorphisms with phenotypic expression, which are significantly associated with clinical manifestation of schizophrenia, can serve as useful genetic markers. The authors highlight that currently there are no certain susceptibility genes. Further global research and search for markers in different population groups are needed.


Subject(s)
Genetic Predisposition to Disease , Schizophrenia/genetics , Endophenotypes , Genetic Markers , Genome-Wide Association Study , Humans , Mutation , Schizophrenia/epidemiology
7.
Article in Russian | MEDLINE | ID: mdl-20639852

ABSTRACT

Glutamate neurotransmission has been considered as one of pathogenetic factors of schizophrenia though all antipsychotics widely used in modern psychiatric practice are dopamine antagonists. LY2140023 is a selective agonist for metabotropic glutamate 2/3 (mGlu2/3) receptors with antipsychotic effect. In the present study, we have assessed clinical efficacy of LY2140023 in patients with schizophrenia compared to the control group receiving olanzapine in a randomized double-blind placebo-controlled trial. The statistically significant reduction of positive and negative symptoms measured with the PANSS (p<0.001) was observed for both antipsychotics at week 4 of treatment compared to placebo. The treatment with LY2140023 was safe and well-tolerated; treated patients did not differ from the placebo group by hyperprolactinemia and extrapyramidal symptoms, and weight gain. The results suggest that the agonist for 2/3 (mGlu2/3) receptors has antipsychotic properties and provides a new, alternative to dopamine agonists, method for pharmacotherapy of schizophrenia.


Subject(s)
Amino Acids/therapeutic use , Antipsychotic Agents/therapeutic use , Receptors, Metabotropic Glutamate/agonists , Schizophrenia/drug therapy , Adolescent , Adult , Aged , Amino Acids/adverse effects , Antipsychotic Agents/adverse effects , Female , Humans , Male , Middle Aged , Treatment Outcome , Young Adult
8.
Article in Russian | MEDLINE | ID: mdl-20037519

ABSTRACT

An aim of the study was to find stress reduction methods preferred by combatants. One hundred and nineteen servicemen who do contract military service in the North Caucasus were questioned. More than a half of them named the support of colleges in arms. The awareness of importance of their aid was correlated with the duration and intensity of experiencing combat stress. Every fifth combatant chose individual combat experience out of all methods. The longer was duration of service in a combat zone, the more increased the subjective significance of personal experience. More than a third of combatants considered alcohol and drugs as effective means for stress reduction. Veterans, who iteratively did military service in military zones and had been wounded, and direct participants of combats named these means even more often. Among those examinees who noted alcohol as an effective mean for stress reduction, 26.6% noted also drugs and 20%--sedatives. The author suggests that the interest of combatants in alcohol and any drug that has an effect on the mental state indicates the higher risk of taking other psychoactive drugs.


Subject(s)
Anti-Anxiety Agents/therapeutic use , Combat Disorders/diagnosis , Military Personnel/psychology , Psychotherapy/methods , Adult , Combat Disorders/therapy , Disease Progression , Follow-Up Studies , Humans , Male , Psychological Techniques , Retrospective Studies , Russia , Severity of Illness Index , Surveys and Questionnaires , Warfare
10.
Voen Med Zh ; 329(4): 44-6, 96, 2008 Apr.
Article in Russian | MEDLINE | ID: mdl-18540415

ABSTRACT

Using the method of nameless interrogation, there were investigated 119 service-men, served by contract on Northern Caucasus. 76,5% of investigated persons recognized different types of distress. The most often, features of psychic ill-being were signed by persons, obtained different wounds. Among typical symptoms of acute stress reactions the most often were the evidences of "invasion" (21%), tension (13,5%), lowed attune (14,3%). It's necessary attend, that involuntary revising and high irritation with an aptitude of evidence of anger often worried participants of warfare. Tension, backward, worried, in general, the persons, not yet participated in warfare. Persons, participated in warfare for the first time,signed the psychic tension rather rare. Lowed attune were signed very rare for the persons, served in the area of contraterrorist actions for the second time and having a big battle experience. During the evaluation of comorbidity of different symptoms of stress disease were signed, that the most often with another types of symptoms are conjoined: high irritation, sense of weariness, sense of fault and lowed attune. These symptoms can serve as markers of tendency to syndrome-making and, that's why, require special attention of psychologist and psychiatrist of military unit of medical service.


Subject(s)
Emotions , Military Personnel/psychology , Psychology, Military , Stress, Psychological/psychology , Warfare , Humans , Russia
11.
Voen Med Zh ; 329(3): 56-62, 112, 2008 Mar.
Article in Russian | MEDLINE | ID: mdl-18488491

ABSTRACT

The article presents the review of neurophysiological and neuro-morphological researches of combat posttraumatic stress disorder. Also in the article presented data about the existence by the veterans, suffered by combat posttraumatic stress disorder, a regular dysfunction of hypothalamus-pituitary-paranephric system, approving by excessive allowance ruffling ofcortisol, tending the activation neuro-trasmitteric systems. These changes conjoin with predominance of sympaticotony and of increased psycho and physiological inflammability in response to cues, associated with real or imaginable danger. Methods of neurovisulisation show the existence of changes in visceral brain, prefrontal and sense-motorical zone of cerebrum, corresponded to stress signals. The article presents the discuss of cause-and-effects conditions between the morphological changes in central nervous system, influence of stress-factors and advance of disease.


Subject(s)
Hypothalamo-Hypophyseal System , Nervous System Physiological Phenomena , Pituitary-Adrenal System , Stress Disorders, Post-Traumatic , Veterans , Humans , Hypothalamo-Hypophyseal System/anatomy & histology , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiology , Organ Size/physiology , Pituitary-Adrenal System/anatomy & histology , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiology , Stress Disorders, Post-Traumatic/metabolism , Stress Disorders, Post-Traumatic/pathology , Stress Disorders, Post-Traumatic/physiopathology , Veterans/psychology
12.
Voen Med Zh ; 328(7): 55-61, 96, 2007 Jul.
Article in Russian | MEDLINE | ID: mdl-17902346

ABSTRACT

peculiarities of battle posttraumatic stress disorder (PTSD) and personal grounds to criminal aggression of 174 veterans of local wars and armed conflicts. It's shown, that the highest probability of accomplishment of socially dangerous actions is at the term of first 3 years after the influence of stress battle factors. More over different PTSD symptoms. These traits concerned to the following spheres: emotional, cognitive and sphere of values. Among pathologic traits of character, especially clear were shown explosive treats of character, hostility, predominatation of negative emotions, hardly one-sided type of judgments, changes in structure of leading motives and values. Sometimes the scale of moral estimations had double character: "our-strange", "friend-enemy". The highest risk of progress of acute stress reactions with aggressive behavior takes place on condition of disphoria-anxious version of PTSD, which is maximally characterized by person's changes, having sthenic character.


Subject(s)
Adaptation, Psychological , Aggression/psychology , Combat Disorders/psychology , Veterans , War Crimes/psychology , Adult , Criminal Psychology , Humans , Male , Psychiatric Status Rating Scales , Russia , Social Adjustment
14.
Article in Russian | MEDLINE | ID: mdl-15490939

ABSTRACT

Depressive state in cancer patients is known to meet the criteria of mild depressive episode (F33.0) according to ICD-10. In the earlier stages of the disease and after successful treatment, depressive symptoms are usually combined with anxiety and obsessive fear, moderate appearances of ideator and motor inhibition, with permanent presence of asthenic symptoms. Once the disease is getting severer and the treatment is less successful, asthenia acquires hyposthenic features, with symptoms of apathy and dysphoria being attached. Cypramil was shown to be an effective medication in the treatment of depression in patients with malignant tumors of gastric-intestinal tract. The most efficient was the treatment conducted on the earlier stages of the cancer process and in cases of successful surgery and chemotherapy, in combination of depression with anxiety, anxious hypochondria, asthenia. Antidepressants must be used together with psychotherapy.


Subject(s)
Citalopram/therapeutic use , Depressive Disorder, Major/drug therapy , Depressive Disorder, Major/etiology , Gastrointestinal Neoplasms/psychology , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adult , Citalopram/administration & dosage , Depressive Disorder, Major/diagnosis , Drug Administration Schedule , Female , Humans , Male , Middle Aged , Selective Serotonin Reuptake Inhibitors/administration & dosage , Severity of Illness Index
15.
Voen Med Zh ; 325(6): 36-41, 80, 2004 Jun.
Article in Russian | MEDLINE | ID: mdl-15327139

ABSTRACT

The article is devoted to the actual problem, i.e. the stress-provoked suicidal behavior in servicemen. Basing on the investigation of 195 servicemen committed the suicidal actions the significance of suicidal behavior prerequisites such as constitutional peculiarities and unfavorable conditions in social environment was determined. General personal features typical of such persons are described. It was established that among them there is a number of quite specific stigmas. It was determined that the presence of contradictions between the marked aggressive radical and impossibility of its realization lead to autoagression. The significance of this problem for the theory and practice of general and forensic psychiatry was revealed.


Subject(s)
Military Personnel , Stress, Psychological/psychology , Suicide/psychology , Adolescent , Adult , Humans , Male , Military Personnel/psychology , Russia , Suicide/statistics & numerical data , Suicide, Attempted/psychology , Suicide, Attempted/statistics & numerical data
17.
Article in Russian | MEDLINE | ID: mdl-12789825

ABSTRACT

Thirty one patients, aged 23-48 years, with ICD-10 diagnosis of psychogenic neurotic depression (F32.0 and F32.1), were studied. According to antidepressants used, the patients were divided into 2 groups, of which the test one included 19 patients treated by cipramil (20-40 mg/day) and the comparative one consisted of 12 patients treated with amitriptilin (25-50 mg/day). The treatment duration was 28 days. The patient's state was evaluated, using clinical approach and instrumental methods, i.e. Hamilton depression scale, before treatment and on 14th and 28th days. After cipramil treatment, 14 patients out of 19 exhibited an improvement, with 5 revealing neurotic symptoms compensation. However, 5 patients proved to be resistant to the medication. In amitriptilin treatment, complete depression reduction was found only in 1 patient, with pronounced improvement being shown in 8 out of 12 patients. No changes in the patient's state were revealed for 3 cases. Cipramil treatment was not accompanied with any side effects.


Subject(s)
Citalopram/therapeutic use , Depressive Disorder/drug therapy , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adult , Humans , Middle Aged , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...